XML 423 R221.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments (Details 10) - BRL (R$)
R$ / shares in Units, R$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Less: Cash and cash equivalents R$ (5,634,623) R$ (2,678,457) R$ (3,472,845)
Net income 2,327,168 1,149,321 5,048,602
Deferred IRPJ and CSLL (17,047) (649,134) 806,344
Provision for IRPJ and CSLL 371,104 368,035 372,180
Depreciation and amortization 1,382,040 1,233,097 R$ 1,017,293
Capital Management [Member]      
IfrsStatementLineItems [Line Items]      
Loans and financing 5,343,217 4,650,363  
Debentures 9,619,106 7,803,855  
Less: Cash and cash equivalents (5,634,623) (2,678,457)  
Less: Bonds and securities (current) (405,342) (290,695)  
Adjusted net debt 8,922,358 9,485,066  
Net income 2,327,168 1,149,321  
Net income from discontinued operations (191,501)  
Net income from continuing operations 2,135,667 1,149,321  
Equity in earnings of investees (307,809) (478,577)  
Deferred IRPJ and CSLL (17,047) (628,389)  
Provision for IRPJ and CSLL 371,104 429,267  
Financial expenses (income), net 1,204,990 1,966,037  
Depreciation and amortization 1,382,040 1,300,982  
Provision for allocation of PIS and Cofins credits 810,563  
(-/+) Impairment (177,693) 84,387  
Adjusted ebitda R$ 4,591,252 R$ 4,633,591  
Adjusted net debt / Ebitda (in R$ per share) R$ 1.94 R$ 2.05